MAGEA3 and myxofibrosarcoma: Similarly, we showed that melanoma-associated antigen 3 (MAGE-A3) is expressed in undifferentiated pleomorphic sarcoma/myxofibrosarcoma and can be incorporated into immunotherapy techniques [3].